Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.

CONCLUSION: In patients aged 2-17 years with pJIA, no evidence of association between higher levels of exposure to intravenous or subcutaneous abatacept and incidence of infection was observed. PMID: 33452173 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33452173?dopt=Abstract

Source: Journal of Rheumatology - January 17, 2021 Category: Rheumatology Tags: J Rheumatol Source Type: research